Netabolics

Startup

Netabolics is a TechBio company based in Rome, Italy, on a mission to drive drug discovery in areas with high unmet medical needs and advance access to precision therapies through mechanistic biosimulation at scale. We envision a future where predictive modeling of human biology is central to personalized medicine, enabling therapies to be tailored with accuracy, speed, and confidence, especially for complex, treatment-resistant conditions.

At the core of our technology is a patented simulation engine that models entire biological networks from first principles to deliver explainable and mechanistically grounded predictions. This allows us to interrogate disease mechanisms, simulate therapeutic scenarios, and anticipate cellular responses with unprecedented depth.

By integrating multi-omics data, ODE-based modeling, and AI-guided simulation, our platform predicts the system-wide effects of genetic and pharmacological interventions on cellular biology, guiding the precise modulation of biological targets through optimized drug combinations, both repurposed and novel.

This technology has demonstrated high retrospective accuracy in preclinical applications. We are actively seeking strategic partnerships to translate these advances into clinical success and bring transformative therapies to patients faster.